Recce Pharmaceuticals Announces Positive Oral Data on New RECCE® 435 Against Helicobacter Pylori in Animal Model

NEXT STORY
Global Cell Analysis Instruments Market (2020 to 2025) – Growth, Trends, and Forecasts
PREV STORY
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Nurse Call Systems Market to Exhibit a CAGR of 11.5% to Reach USD 2.79 Billion by 2026; Decreasing Number of Patient to Nurse Ratio to Boost Growth, says Fortune Business Insights

author_avatar
NASDAQ Market News

MacroGenics Announces Second Interim Overall Survival Data from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer

author_avatar
NASDAQ Market News

Junshi Biosciences Announces Expansion of Emergency Use Authorization for Etesevimab and Bamlanivimab Administered Together to Include Post-Exposure Prophylaxis for COVID-19

author_avatar
NASDAQ Market News